Maze Therapeutics MAZE
NASDAQ MAZE
$32.73 +0.28 (+0.86%)
As of: Oct 21, 2026 · 12:45 PM EDT

Maze Therapeutics (MAZE) Operating Margin (2024 - 2026)

Updated

Maze Therapeutics (MAZE) posted Operating Margin of -132.77% for Q1 2026.

Analysis

Maze Therapeutics (MAZE) Operating Margin (2024 - 2026) Analysis & Trends

For FY2024, Maze Therapeutics' Operating Margin came in at 34.38%.

  • The Q1 2026 figure stands as the highest quarterly Operating Margin since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,132.21 Bn 1,100.80 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 616.27 Bn 534.80 Bn 17.26 Bn 28.21%
3 AbbVie 500.10 Bn 473.21 Bn 12.70 Bn 37.86%
4 Merck 366.86 Bn 321.23 Bn 12.21 Bn -3.52%
5 Novartis Ag 297.92 Bn 261.91 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.53 Bn 235.22 Bn 12.86 Bn 20.57%
7 Amgen 234.99 Bn 190.39 Bn 7.24 Bn 34.95%
8 Gilead Sciences 190.14 Bn 164.34 Bn 6.22 Bn -133.21%
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn 28.37%
10 Maze Therapeutics 1.93 Bn 439.26 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -132.77%
Sep 30, 2024 -969.16%
Jun 30, 2024 84.58%
API Access

Maze Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=MAZE&period=max&api_key=YOUR_API_KEY